Cargando…
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
Autores principales: | Belen-Apak, F. Burcu, Sarıalioğlu, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200048/ https://www.ncbi.nlm.nih.gov/pubmed/32372336 http://dx.doi.org/10.1007/s11239-020-02129-0 |
Ejemplares similares
-
Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2016) -
Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
por: Güner, Ahmet, et al.
Publicado: (2021) -
Massive pulmonary embolism and cardio-pulmonary resuscitation leading to disseminated intravascular coagulation
por: Fyyaz, Madiha, et al.
Publicado: (2011) -
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?
por: Belen-Apak, F.B., et al.
Publicado: (2020) -
Thrombotic Thrombocytopenic Purpura or Disseminated Intravascular Coagulation?
por: Pannu, Ashok Kumar, et al.
Publicado: (2017)